Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Published:2005-09-23 Issue:3 Volume:13 Page:253-265
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Varghese S,Rabkin S D,Liu R,Nielsen P G,Ipe T,Martuza R L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700900.pdf

Reference61 articles.

1. Kitano H . Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 2004; 4: 227–235.

2. Rodriguez PC, Zea AH, Ochoa AC . Mechanisms of tumor evasion from the immune response. Cancer Chemother Biol Response Modif 2003; 21: 351–364.

3. Markiewicz MA, Kast WM . Advances in immunotherapy for prostate cancer. Adv Cancer Res 2003; 87: 159–194.

4. Strohmeyer DM, Berger AP, Moore II DH, Bartsch G, Klocker H, Carroll PR et al. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate 2004; 59: 43–58.

5. Leibovitz A, Baumoehl Y, Segal R . Increased incidence of pathological and clinical prostate cancer with age: age related alterations of local immune surveillance. J Urol 2004; 172: 435–437.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

3. PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway;Journal of Experimental Medicine;2024-06-13

4. Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer;Frontiers in Immunology;2024-05-15

5. The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management;Cellular & Molecular Biology Letters;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3